112 related articles for article (PubMed ID: 30464683)
1. Discrepancies between Canadian cancer research funding and site-specific cancer burden: a spotlight on ten disease sites.
Coronado AC; Finley C; Badovinac K; Han J; Niu J; Rahal R
Curr Oncol; 2018 Oct; 25(5):338-341. PubMed ID: 30464683
[TBL] [Abstract][Full Text] [Related]
2. Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis.
Maruthappu M; Head MG; Zhou CD; Gilbert BJ; El-Harasis MA; Raine R; Fitchett JR; Atun R
BMJ Open; 2017 Apr; 7(4):e013936. PubMed ID: 28428185
[TBL] [Abstract][Full Text] [Related]
3. An analysis of discrepancies between United Kingdom cancer research funding and societal burden and a comparison to previous and United States values.
Carter AJ; Delarosa B; Hur H
Health Res Policy Syst; 2015 Nov; 13():62. PubMed ID: 26526609
[TBL] [Abstract][Full Text] [Related]
4. The allocation of USdollar;105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments.
Head MG; Brown RJ; Newell ML; Scott JAG; Batchelor J; Atun R
Lancet Glob Health; 2020 Oct; 8(10):e1295-e1304. PubMed ID: 32971052
[TBL] [Abstract][Full Text] [Related]
5. A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding.
Carter AJ; Nguyen CN
BMC Public Health; 2012 Jul; 12():526. PubMed ID: 22800364
[TBL] [Abstract][Full Text] [Related]
6. A Comparative Analysis of Survival and Funding Discrepancies in Cancers With High Mortality.
Hall BR; Cannon A; Atri P; Wichman CS; Smith LM; Kumar S; Batra SK; Wang H; Ganti AK; Sasson AR; Are C
Ann Surg; 2020 Feb; 271(2):296-302. PubMed ID: 30188400
[TBL] [Abstract][Full Text] [Related]
7. Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds.
Burnet NG; Jefferies SJ; Benson RJ; Hunt DP; Treasure FP
Br J Cancer; 2005 Jan; 92(2):241-5. PubMed ID: 15655548
[TBL] [Abstract][Full Text] [Related]
8. Mapping the European cancer research landscape: An evidence base for national and Pan-European research and funding.
Begum M; Lewison G; Lawler M; Sullivan R
Eur J Cancer; 2018 Sep; 100():75-84. PubMed ID: 30014883
[TBL] [Abstract][Full Text] [Related]
9. Research investments for UK infectious disease research 1997-2013: A systematic analysis of awards to UK institutions alongside national burden of disease.
Head MG; Brown RJ; Clarke SC
J Infect; 2018 Jan; 76(1):11-19. PubMed ID: 29061335
[TBL] [Abstract][Full Text] [Related]
10. Underfunding of stroke research: a Europe-wide problem.
Pendlebury ST; Rothwell PM; Algra A; Ariesen MJ; Bakac G; Czlonkowska A; Dachenhausen A; Krespi Y; Kõrv J; Krolikowski K; Kulesh S; Michel P; Thomassen L; Bogousslavsky J; Brainin M
Stroke; 2004 Oct; 35(10):2368-71. PubMed ID: 15308781
[TBL] [Abstract][Full Text] [Related]
11. Resource allocation to brain research in Europe (RABRE).
Sobocki P; Lekander I; Berwick S; Olesen J; Jönsson B
Eur J Neurosci; 2006 Nov; 24(10):2691-3. PubMed ID: 17156195
[TBL] [Abstract][Full Text] [Related]
12. UK investments in global infectious disease research 1997-2010: a case study.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Hayward AC; Atun R
Lancet Infect Dis; 2013 Jan; 13(1):55-64. PubMed ID: 23140942
[TBL] [Abstract][Full Text] [Related]
13. The relation between funding by the National Institutes of Health and the burden of disease.
Gross CP; Anderson GF; Powe NR
N Engl J Med; 1999 Jun; 340(24):1881-7. PubMed ID: 10369852
[TBL] [Abstract][Full Text] [Related]
14. The case for increased funding for research in pulmonary and critical care.
Peters-Golden M; Klinger JR; Carson SS;
Am J Respir Crit Care Med; 2012 Aug; 186(3):213-5. PubMed ID: 22582163
[TBL] [Abstract][Full Text] [Related]
15. Research output and the public health burden of cancer: is there any relationship?
Patafio FM; Brooks SC; Wei X; Peng Y; Biagi J; Booth CM
Curr Oncol; 2016 Apr; 23(2):75-80. PubMed ID: 27122971
[TBL] [Abstract][Full Text] [Related]
16. Disparities in National Cancer Institute and Nonprofit Organization Funding Disproportionately Affect Cancers With Higher Incidence Among Black Patients and Higher Mortality Rates.
Kamath SD; Chen Y
JCO Oncol Pract; 2024 Mar; 20(3):378-385. PubMed ID: 38190584
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Cancer Burden and Nonprofit Organization Funding Reveals Disparities in Funding Across Cancer Types.
Kamath SD; Kircher SM; Benson AB
J Natl Compr Canc Netw; 2019 Jul; 17(7):849-854. PubMed ID: 31319386
[TBL] [Abstract][Full Text] [Related]
18. The anatomy of medical research: US and international comparisons.
Moses H; Matheson DH; Cairns-Smith S; George BP; Palisch C; Dorsey ER
JAMA; 2015 Jan; 313(2):174-89. PubMed ID: 25585329
[TBL] [Abstract][Full Text] [Related]
19. Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997-2013.
Head MG; Fitchett JR; Newell ML; Scott JA; Harris JN; Clarke SC; Atun R
EBioMedicine; 2015 Sep; 2(9):1193-9. PubMed ID: 26501117
[TBL] [Abstract][Full Text] [Related]
20. Brain research has high returns but Europe is lagging behind.
Sobocki P; Olesen J; Jönsson B
Eur J Neurol; 2007 Jun; 14(6):708-10. PubMed ID: 17539958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
